Hylomorph Medical raises €3.4M Series A round
16 September 2018· Zurich, Switzerland· health, medical_devices, biomaterials, biotech, b2b, deep_hardware
The funding will allow the company to finalize product development and conduct clinical studies required for FDA approval and CE-Marking.
Investors
LeadFongit Seed Invest
Also participating
Zürcher KantonalbankStart Angel Network ZurichInvestiere
About Hylomorph Medical
Stage
Series B
Headquarters
Zurich, Switzerland
Founded
2014
Team Size
6–20
Sectors
healthmedical_devicesbiomaterialsbiotechb2bdeep_hardware
Source: https://venturekick.ch/Hylomorph-secures-CHF-3-2m-Series-A-round